NICE Agrees Cost-reducing Scheme For New Cancer Drug Trabectedin, UK
Links shared publicly online about this topic.
- 1,486total visits
NICE Agrees Cost-reducing Scheme For New Cancer Drug Trabectedin, UK
Patients with a rare form of cancer called advanced soft tissue sarcoma could now benefit from a new drug called trabectedin, after the national institute for health and clinical excellence (nice)
View full resource at medicalnewstoday.com
Tags: Cancer, Cancer Medication, Drug
Most Recently Shared on January 2, 2010 at 11:04 am By:
NICE Agrees Cost-reducing Scheme For New Cancer Drug Trabectedin, UK http://mnt.to/3vQV
Advertisement
